Showing results (181-190 of 300) with videos related to

Sort By:
Pageof 30
International Journal of Antimicrobial Agents|December 5, 2022
Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018Elsa Nyamankolly, Pantxika Bellecave, Linda Wittkop, et al.
AIDS (London, England)|February 9, 2016
Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?David C Boettiger, Caroline A Sabin, Andrew Grulich, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2023
Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)Jihane Ben Farhat, Mojgan Hessamfar, Sophie Farbos, et al.
IJID Regions|July 21, 2025
Real-world effectiveness, safety, and health-related quality of life in people living with HIV receiving bictegravir/emtricitabine/tenofovir alafenamide-12-month results of the BICSTaR French cohortLaurent Hocqueloux, Fabrice Bonnet, Claudine Duvivier, et al.
Clinical Pharmacology and Therapeutics|February 6, 2021
Neglecting Plasma Protein Binding in COVID-19 Patients Leads to a Wrong Interpretation of Lopinavir OverexposureFrancoise Stanke-Labesque, Didier Concordet, Zoubir Djerada, et al.
Antiviral Therapy|December 25, 2009
Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study, Julia Bohlius, Kurt Schmidlin, et al.
AIDS (London, England)|June 18, 2009
Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy, Julia Bohlius, Kurt Schmidlin, et al.
The Journal of Infectious Diseases|December 4, 2012
Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine CohortLinda Wittkop, Juliette Bitard, Estibaliz Lazaro, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
Scientific Reports|October 24, 2024
Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trialFabrice Bonnet, Adama Doumbia, Vanessa Machault, et al.
Pageof 30